World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

DOES METHOTREXATE CAUSE MENORRHAGIA? A CASE REPORT OF MENORRHAGIA IN A PATIENT WITH PSORIATIC ARTHRITIS

Dr. Betul Celik* and Dr. Bulent Potur

ABSTRACT

Dear Editor, besides cancer chemotherapy and tumor arena, methotrexate (MTX), an anti-metabolite drug has been used for the treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA) and psoriasis since 1980s and has become the cornerstone of RA therapy.[1,2,3] Methotrexate acts on folate metabolism. It inhibits dihydrofolate reductase and prevents the synthesis of tetra hydro folate from dihydrofolate. As a result, the synthesis of timidilate, purine and ultimately DNA is blocked. Induction of apoptosis is, in part, responsible for its therapeutic effects,[4,5,6,7] so patient having this medication is closely monitored for possible side effects on liver but also for other organs.[8,9] To our knowledge, there is no information regarding interaction between heavy menorrhagia, endometrial hyperplasia, and MTX use in a woman at reproductive age. We here presented a patient who was admitted to our hospital because of a continued and heavy menorrhagia for 11 days.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR